2
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Occurrence of pregnancy and pregnancy outcomes during isotretinoin therapy

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Isotretinoin, a teratogen, is widely used to treat cystic acne. Although the risks of pregnancy during isotretinoin therapy are well recognized, there are doubts about the level of adherence with the pregnancy prevention program in Canada. Our objective was to evaluate the effectiveness of the Canadian pregnancy prevention program in 4 provinces: British Columbia, Saskatchewan, Manitoba and Ontario.

          Related collections

          Author and article information

          Journal
          Canadian Medical Association Journal
          CMAJ
          Joule Inc.
          0820-3946
          1488-2329
          July 11 2016
          July 12 2016
          : 188
          : 10
          : 723-730
          Article
          10.1503/cmaj.151243
          4938682
          27114489
          c79b582b-4765-40f5-a447-300393267724
          © 2016
          History

          Comments

          Comment on this article